Risk/benefit ratio in enuresis therapy.
Fitzwater
D
D
Macknin
M L
ML
D000293:Adolescent; D002648:Child; D002675:Child, Preschool; D003362:Cost-Benefit Analysis; D003894:Deamino Arginine Vasopressin / Q000191:economics / Q000627:therapeutic use; D004775:Enuresis / Q000191:economics / Q000628:therapy*; D006801:Humans; D007099:Imipramine / Q000627:therapeutic use; D012306:Risk; D016896:Treatment Outcome
D003894:Deamino Arginine Vasopressin; D007099:Imipramine